Cantel Education Days 2019 in Belgium with Marjon de Pater

Marjon de Pater (President of ESGENA) and Hilde Willekens (Endoscopy UZ Leuven) will present on Tuesday 7th May the new publication of the ESGENA Guidelines and how to integrate these into their daily endoscopy department routine. 

The presentation takes place at the hospital AZ Leuven.

ESCAD Medical becomes Cantel (Production) Germany GmbH

As of June 1, 2018, ESCAD Medical officially becomes Cantel (Production) Germany GmbH. The US company Cantel had taken over the BHT Group and thus also ESCAD Medical last summer.

Cantel Medical Acquires Aexis Medical

Acquisition further advances global leadership position in infection prevention through entry into healthcare information analytics market.

Cantel Medical Completes Acquisition of BHT Group in Germany

CANTEL MEDICAL CORP. (NYSE:CMD) announced today that it has completed its previously announced acquisition of BHT Hygienetechnik Holding GmbH (“BHT Group”).

Cantel Medical Acquires Medical Innovations Group

Acquisition of global endoscope storage and transport manufacturer further expands Cantel Medical's endoscopy infection prevention & control portfolio

Cantel Medical Acquires International Medical Service S.r.l.

LITTLE FALLS, N.J., Nov. 4, 2014 - CANTEL MEDICAL CORP. (NYSE: CMN) today announced that it acquired International Medical Service S.r.l, or IMS, for a purchase price of €19.6 million in cash consideration. Located in Pomezia, Italy, IMS is a leading manufacturer of high-level disinfectant chemistries used in automated endoscope reprocessors (AERs) as well as other infection prevention and control chemistries used in healthcare and dental markets. In addition, IMS is a manufacturer of high-quality AERs and holds leading share in the Italian AER market. IMS has an employee base of approximately 60 individuals including a complete sales and service team for the Italian market as well as a robust engineering group.

Cantel Medical Completes Acquisition Of PuriCore International Ltd.

July 1st, 2014 - CANTEL MEDICAL CORP. (NYSE:CMN), today announced that the company has successfully completed the acquisition of PuriCore International Limited., a wholly-owned subsidiary of PuriCore plc (LSE:PURI).

The transaction further enhances Cantel Medical's global leadership of automated endoscope reprocessing and provides the company with additional resources and capabilities to execute on its broader international strategy. PuriCore International Limited will be renamed Cantel Medical (UK) Limited and will be reported as part of our Endoscopy segment.

We use cookies on this website to ensure that the site will work properly. If you click ‘OK’ or continue to use this website by navigating to another page you are agreeing to our use of cookies.

More information